{
    "xml": "<topic id=\"PHP81534\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/cervarix\" basename=\"cervarix\" title=\"Cervarix\">\n<title>Cervarix<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP81884\" outputclass=\"indicationsAndDose\" rev=\"1.45\" parent=\"/clinical-medicinal-product-information/cervarix\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of premalignant genital lesions and cervical cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child female\">\n<p>Child 9&#8211;14 years (female)</p>\n<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 5&#8211;7&#8239;months for 1 dose, if second dose administered earlier than 5 months after the first, a third dose should be administered, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, even if more than 24 months have elapsed since the first dose or if the girl is then aged 15 years or more.</p>\n</li>\n<li outputclass=\"patientGroup child female\">\n<p>Child 15&#8211;17 years (female)</p>\n<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 1&#8211;2.5&#8239;months for 1 dose, then 0.5&#8239;mL after 5&#8211;12&#8239;months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.</p>\n</li>\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 1&#8211;2.5&#8239;months for 1 dose, then 0.5&#8239;mL after 5&#8211;12&#8239;months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP81534",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/cervarix",
    "basename": "cervarix",
    "title": "Cervarix",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prevention of premalignant genital lesions and cervical cancer",
                        "html": "Prevention of premalignant genital lesions and cervical cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "child female": [
                    {
                        "textContent": "0.5 mL for 1 dose, followed by 0.5 mL after 5&#8211;7 months for 1 dose, if second dose administered earlier than 5 months after the first, a third dose should be administered, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, even if more than 24 months have elapsed since the first dose or if the girl is then aged 15 years or more.",
                        "html": "<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 5&#8211;7&#8239;months for 1 dose, if second dose administered earlier than 5 months after the first, a third dose should be administered, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, even if more than 24 months have elapsed since the first dose or if the girl is then aged 15 years or more.</p>",
                        "ageGroup": "child 9&#8211;14 years (female)"
                    },
                    {
                        "textContent": "0.5 mL for 1 dose, followed by 0.5 mL after 1&#8211;2.5 months for 1 dose, then 0.5 mL after 5&#8211;12 months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.",
                        "html": "<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 1&#8211;2.5&#8239;months for 1 dose, then 0.5&#8239;mL after 5&#8211;12&#8239;months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.</p>",
                        "ageGroup": "child 15&#8211;17 years (female)"
                    }
                ],
                "adult female": [
                    {
                        "textContent": "0.5 mL for 1 dose, followed by 0.5 mL after 1&#8211;2.5 months for 1 dose, then 0.5 mL after 5&#8211;12 months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.",
                        "html": "<p>0.5&#8239;mL for 1 dose, followed by 0.5&#8239;mL after 1&#8211;2.5&#8239;months for 1 dose, then 0.5&#8239;mL after 5&#8211;12&#8239;months for 1 dose, dose to be administered into deltoid region, if the course is interrupted, it should be resumed (using the same vaccine) but not repeated, allowing the appropriate interval between the remaining doses.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}